2012 AABB/SABM Webinar Series
AABB and SABM are proud to offer a new webinar series focused on patient blood management (PBM). Covering topics such as an overview of a PBM program; case studies in obstetrics, ICU patients and hematology/oncology patients; and collecting and analyzing PBM data, this 8-part series features one program on the second Thursday of each month from January to August. Experts in the field of will share their knowledge and experience with the audience while answering questions from program participants.
These programs, 1 hour in length, are offered for individuals. Because both the audio and visual presentations will be available on the Internet, attendees will only need access to a computer to participate.
Registration Fees & Process Information
|
Single Program |
Full Series
(8 webinars) |
| Individual Member |
$39 |
$224 |
| Individual Nonmember |
$59 |
$384 |
To take advantage of the package savings, you must purchase all the programs at one time.
To register for this series, individuals must purchase the programs online through the AABB Marketplace. Purchases can be made up until 1:00PM (ET) on the day of the program. Please note that one paid registration covers one log-in and access to the live program.
The AABB Education and Professional Development Department will email participants instructions on how to access the webinar the day prior to each program.
Continuing education credit is offered for this AABB educational activity for the individuals registered for the live webinars. Registrants will receive an email with instructions on how to access their CME information within a week of the program’s conclusion.
Recorded versions of past webinars can be purchased through the AABB Marketplace as they become available. Individuals will receive an email within a week of their purchase with instructions on how to access the recording.
Cancellations
All cancellations must be made in writing and sent to professionaldevelopment@aabb.org. Cancellations received by AABB at least 48 hours prior to a program will receive a refund less a $10 administrative fee per webinar. There will be no refunds for cancellations within 48 hours of a webinar.
Overview of a Patient Blood Management Program
Thursday, January 12, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1220
Speaker: Mary Ghiglione, RN, MSN, MHA, National Director Blood Management, aLab Services
Objectives:
- Identify rationale for implementing a PBM program.
- Identify components of a PBM program.
- Identify quality indicators for PBM programs.
Description: Patient blood management is the scientific use of safe and effective medical and surgical techniques designed to prevent anemia and decrease bleeding in an effort to improve patient outcomes. In light of mounting evidence that transfusions are associated with adverse outcomes, the concept of PBM continues to be more relevant to patient safety and care. The overview of a PBM Program lecture will help participants understand the basics of PBM including: understand the rationale for implementing a program, identify components of a PBM program and identify quality indicators for PBM programs.
Purchase this Recording
Trauma Patient Blood Management Case Studies
Thursday, February 9, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1221
Speaker: Jeffrey L. Kashuk, MD, FACS, Director of Trauma, Surgical Critical Care and Acute Care Surgery, St. Mary’s of Michigan and Midwestern Surgical Associates
Objectives:
- Review the unique challenges that the blood bank encounters in dealing with traumatic injuries and massive transfusion protocol development.
- Describe the current state of the art of coagulation assessment in the postinjury setting.
- Explain the essential role of viscoelastic tests of blood coagulation for assessment of postinjury coagulopathy and goal directed therapy.
Description: The current approach to postinjury coagulopathy is characterized by three primary controversies that directly affect the blood bank and product use. One is the pathophysiology and etiology of the acute coagulopathy of trauma, while a second is the appropriate use of blood products or blood product ratios for resuscitation of the traumatically injured patient. A third controversy is the best method of assessing the patient either at risk or with ongoing issues related to postinjury coagulopathy. This presentation will address all of these controversies, and will serve as an overview of the current state-of-the-art approach to this topic.
Purchase this Recording
Orthopedic Patient Blood Management Case Studies
Thursday, March 8, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1222
Speaker: Brian R. Hamlin, MD, Associate Director, The Orthopaedic Program, Magee Womens Hospital of the University of Pittsburgh Medical Center
Objectives:
- Review the risks of blood transfusion in the setting of total joint arthroplasty.
- Determine the role of a comprehensive blood management program in the setting of total joint arthroplasty.
- Examine newer techniques and processes to lessen risk of transfusion in total joint arthroplasty.
Description: It has become evident that an effective program for blood management is necessary and useful in the practice of total joint arthroplasty, where the use of blood products has been shown to be detrimental to patients. This webinar will review what is known regarding the harmful and costly effects of both allogeneic and autologous blood transfusion in this setting. A comprehensive approach will be presented that allows reduced risk of transfusion of red cells while improving clinical outcomes.
Purchase this Recording
Hematology/Oncology Patient Blood Management Case Studies
Thursday, April 12, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1223
Speaker: Patricia A. Ford, MD, Director, Center for Bloodless Medicine and Surgery, Pennsylvania Hospital
Objectives:
- Review the pathophysiology of anemia and thrombocytopenia in oncology patients.
- Recall five effective blood management strategies for oncology patients.
- Identify continuing challenges in blood management for specific oncology patient populations, including Jehovah's Witnesses and acute leukemia patients.
Description: Anemia and thrombocytopenia are common side effects of chemotherapy in oncology patients and are also associated with the biology of cancer. These hematological disorders can significantly impact the mortality, morbidity, and quality of life in oncology patients. In this session, the etiologies of anemia and thrombocytopenia in oncology patients and the strategies for managing these blood disorders, including the use of erythropoiesis stimulating agents (ESAs), IV iron, and hemostatic agents will be discussed. The speaker will highlight effective treatment strategies for Jehovah's Witness oncology patients who do not accept blood products, using bloodless medicine, which can be applied to all patients for a more efficient recovery. In addition, continuing challenges in blood management such as the treatment of Jehovah's Witness acute leukemia patients will be discussed.
Purchase this Recording
ICU Patient Blood Management Case Studies
Thursday, May 10, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1224
Speaker: Marisa Marques, MD, Professor of Pathology, University of Alabama at Birmingham Hospital
Objectives:
- Review the findings of randomized controlled trials regarding outcomes of patients receiving a restrictive versus a liberal transfusion approach.
- Demonstrate the risks associated with transfusion of PRBCs in hospitalized patients.
- Provide examples of how to avoid transfusions.
Description: Transfusion of Red Blood Cells (RBCs) may be lifesaving or potentially harmful depending on the clinical situation of the patient. In those with massive ongoing bleeding, the use of transfusion may avoid a fatal outcome. On the contrary, in hemodynamically stable patients, even in critical care units, the evidence of randomized clinical trials suggests that a restrictive approach to transfusion is just as effective and even safer than the indiscriminate use of RBC units. Much research is still in progress in order to determine exactly how transfusions increase morbidity and mortality in critically ill patients. Some of the postulated mechanisms include the red cell storage lesion and the induction of transfusion related-immunomodulation (TRIM).
Purchase this Recording
Cardiovascular Patient Blood Management Case Studies
Thursday, June 14, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1225
Speaker: Victor A. Ferraris, MD, PhD, Professor in Vascular Surgery, Division of Cardiothoracic Surgery, University of Kentucky College of Medicine
Objectives:
- Identify patients at high risk for bleeding during cardiac operations.
- Recognize and apply guideline driven blood management interventions during the perioperative period.
- Recognize the value of team-based blood management interventions.
Description: Evidence-based guidelines serve as a starting point for blood management in cardiac surgery. The goal of this program is to outline guideline recommendations that are useful during cardiac operations and to highlight certain blood management interventions that help limit practice variation and reduce costly bleeding and blood transfusion. Emphasis will be placed on the value of blood management teams in implementing evidence based blood conservation interventions.
Purchase
Obstetrics Patient Blood Management Case Studies
Thursday, July 12, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1226
Speaker: Jonathan H. Waters, MD, Medical Director of the University of Pittsburgh Health System’s Perioperative Blood Management program and Chief of Anesthesia Services, Magee-Womens Hospital of the University of Pittsburgh Medical Center
Objectives:
- Identify high-risk obstetrics procedures and the incidence and clinical manifestations of postpartum hemorrhage.
- Review blood management options that can be used to avoid allogeneic transfusion.
- Discuss the use of blood recovery during delivery.
Description: This program will explain the process improvements for transfusion medicine support of labor and delivery services, including management of postpartum hemorrhage, Rh Immune Globulin prophylaxis and blood specimen ordering using blood type and antibody screen algorithms.
Purchase
Data Collection: How to Collect, Analyze and Utilize the Data Collected
Thursday, August 9, 2012
2:00-3:00PM (ET) 7:00-8:00PM (GMT)
Program # 1227
Speaker: Irwin Gross, MD, Director, Transfusion Services, Eastern Maine Medical Center
Objectives:
- Explain the value of blood measures or indicators.
- Describe the value and use of numerator and denominator data in monitoring and auditing a process.
- List possible tools to facilitate the collection and analysis of data for process and outcome improvement.
Description: Process and outcome improvement in blood ordering and utilization is achievable through analysis of data collected. Establishment of blood measures or indicators that are evidence-based and accepted by attending physicians are parameters for data collection. Collection of the data can be tedious and time consuming; however, manual or automated tools can facilitate the process. The webinar will discuss electronic tools that can facilitate data collection and analysis during the performance of audits.
Purchase